Literature DB >> 9448647

Central motor conduction time by magnetic stimulation of the cortex and peripheral nerve conduction follow-up studies in Friedreich's ataxia.

A Cruz-Martínez1, F Palau.   

Abstract

A follow-up clinical study, peripheral motor and sensory nerve conduction velocities and central motor conduction by magnetic stimulation of the cortex were performed in 13 patients with classical Friedreich's ataxia (FA) phenotype, for a period of 9-12 years. Clinical worsening was unrelated to peripheral nerve abnormalities. The amplitude of the nerve action potentials and delayed conduction velocity remained unchanged for several years. Central motor conduction times were abnormal in all patients. Clinical conditions worsened significantly between successive examinations with significant increments in threshold and significant decrement of the amplitude of motor evoked potentials. The results are consistent with progressive pyramidal and cerebellar pathways involvement as the cause of clinical worsening in FA.

Entities:  

Mesh:

Year:  1997        PMID: 9448647     DOI: 10.1016/s0924-980x(97)00047-7

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  5 in total

1.  Frataxin Restoration in the Nervous System: Possibilities for Gene Therapy.

Authors:  David R Lynch; Elizabeth Kichula; Hong Lin
Journal:  Mol Ther       Date:  2018-06-30       Impact factor: 11.454

Review 2.  Transcranial magnetic stimulation in children.

Authors:  Marjorie A Garvey; Volker Mall
Journal:  Clin Neurophysiol       Date:  2008-01-24       Impact factor: 3.708

Review 3.  Transcranial magnetic stimulation in child neurology: current and future directions.

Authors:  Richard E Frye; Alexander Rotenberg; Molliann Ousley; Alvaro Pascual-Leone
Journal:  J Child Neurol       Date:  2007-12-03       Impact factor: 1.987

4.  Hand Dexterity and Pyramidal Dysfunction in Friedreich Ataxia, A Finger Tapping Study.

Authors:  Gilles Naeije; Antonin Rovai; Massimo Pandolfo; Xavier De Tiège
Journal:  Mov Disord Clin Pract       Date:  2020-12-21

5.  Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer.

Authors:  Sahika Cingir Koker; Ermira Jahja; Huma Shehwana; Ayse Gokce Keskus; Ozlen Konu
Journal:  PLoS One       Date:  2018-12-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.